Search Results 4721-4730 of 33523 for oral

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Departments that treat this condition · Cancer Care at Mayo Clinic · Head and Neck Cancer Center · Mayo Clinic Children's · Neurosurgery · Oncology (Medical) · Oral ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Chang, M.D.. Otolaryngologist. Phoenix, AZ. Areas of focus: Transoral robotic ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Areas of focus: Transoral robotic surgery, Parathyroidectomy, Reconstructive ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Transoral robotic surgery, Parathyroidectomy, Reconstructive surgery, Oral surgery, Microvascular reconstruction, Trans...oral laser microsurgery, Facial ...

  5. Physical Medicine and Rehabilitation Residency (Florida) - Curriculum

    You may also complete mock oral exams twice each year, conducted by Mayo Clinic's PM&R faculty. These oral exams prepare you for the second part of the ...

  6. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  7. Updates from trials of microbiome restoration products - Mayo Clinic

    An investigational oral microbiome drug, CP101, for the prevention of recurrent C. difficile infection: A randomized, placebo-controlled, multi-center trial ...

  8. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

    Participant is able to take oral medication. Registration Exclusion Criteria: Participant has had a prior allogeneic transplant. Participant has Karnofsky ...

  9. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

    - Participants who are on a stable dose of oral diabetes medication >= 2 weeks prior to initiation of study drug treatment are eligible for enrollment

  10. Dermatology - Clinical trials

    The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD (cases) as ...